Cancer information / Cancer types / Kidney / Treatment / Recurrent

American Cancer Society. (2015, March 3). Kidney Cancer (Adult) - Renal Cell Carcinoma.

Bex A, Gore M, Mulders P, et al. Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care. (2012). BJU International. London, UK: Wiley. 110: pp.1289-1300.

Cowey LC & Hutson TE. Personalized medicine and targeted therapy of renal cell carcinoma. Tan, Donfeng & Lynch, Henry T (eds.). (2013). Principles of Molecular Diagnostics and Personalized Cancer Medicine. Lippincott Williams & Wilkins. 65.

Drugs and Health Products, Health Canada. (2016, April 25). Regulatory Decision Summary:Opdivo. Retrieved from:

Escudier B, Albiges L, & Sonpavde G. Optimal management of metastatic renal cell carcinoma: current status. (2013). Drugs. Springer. 73: pp. 427-38.

Karam JA & Wood CG. Surgical management of metastatic/advanced kidney cancer. Scardino PT, Lineham WM, Zelefsky MJ & Vogelzang NJ (eds.). (2011). Comprehensive Textbook of Genitourinary Oncology. (4th Edition). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. 45D: pp. 795-802.

Lane, BR, Canter DJ, Rini BJ, Uzzo RG. Cancer of the kidney. DeVita VT Jr, Lawrence TS, & Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Edition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins.

Leveridge MJ & Jewett MAS. Recent developments in kidney cancer. (2011). Canadian Urological Association Journal. Canadian Urological Association. 5(3);195-203; DOI:10.5489/cuaj.10148.

National Cancer Institute. (2015, February 25). Renal Cell Cancer (PDQ®): Treatment - Health Professional Version.

National Comprehensive Cancer Network. (2014). NCCN Clinical Practice Guidelines in Oncology.

North, S, Basappa N, Bjarnason G, et al. Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 consensus update. (2013). Canadian Urological Association Journal. Montreal: Canadian Urological Association. 7(7-8): pp.238-43.